Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NOBEL ILAC Sanayii ve Ticaret A.S

Latest From NOBEL ILAC Sanayii ve Ticaret A.S

Turkey: Produce Selected Drugs Locally Or Lose Reimbursement

Turkey’s public payer body has said it will halt reimbursement of 54 products from 2018 unless manufacturers, including several multinationals, agree to start local production within a year.

Turkey Policy

Turkey Jostles For Slice Of Biologics Manufacturing Pie

Many local pharma companies in Turkey have been launching capital investments in new production facilities for biologics and biosimilars in the hope of attracting new foreign partners and have already met with some success, but a number of obstacles remain.

Turkey Manufacturing

Turkey Launches Major New Biologics Projects

The Scientific and Technological Research Council of Turkey (TUBITAK) has kicked off two major new projects for biologics, one to develop and produce a biosimilar cancer drug and the other for a pandemic influenza vaccine.

BioPharmaceutical Turkey

Turkey Company Roundup: Biosimilar Pact, Keytruda Supply, Takeda Deal

TUBITAK (The Scientific and Technological Research Council of Turkey) will produce biosimilars with Nobel Ilac, MSD provides pembrolizumab free to 25 patients in Turkey, Abdi Ibrahim intensifies its R&D efforts, and Takeda purchases a portfolio of new products.

BioPharmaceutical Turkey
See All

Company Information

  • Industry
  • Pharmaceuticals